UK markets open in 56 minutes
  • NIKKEI 225

    29,051.48
    +176.25 (+0.61%)
     
  • HANG SENG

    29,263.00
    +380.54 (+1.32%)
     
  • CRUDE OIL

    73.48
    +0.18 (+0.25%)
     
  • GOLD FUTURES

    1,779.20
    +2.50 (+0.14%)
     
  • DOW

    34,196.82
    +322.58 (+0.95%)
     
  • BTC-GBP

    24,816.12
    +1,066.54 (+4.49%)
     
  • CMC Crypto 200

    830.80
    +44.18 (+5.62%)
     
  • ^IXIC

    14,369.71
    +97.98 (+0.69%)
     
  • ^FTAS

    4,051.12
    +11.72 (+0.29%)
     

SYNLAB to continue providing COVID-19 testing at UEFA competition matches and UEFA EURO 2020

  • Oops!
    Something went wrong.
    Please try again later.
·4-min read
  • Oops!
    Something went wrong.
    Please try again later.

DGAP-News: SYNLAB AG / Key word(s): Contract/Alliance
10.06.2021 / 07:30
The issuer is solely responsible for the content of this announcement.

SYNLAB AG
Moosacher Straße 88
80809 Munich
Germany

 

SYNLAB to continue providing COVID-19 testing at UEFA competition matches and UEFA EURO 2020
 

SYNLAB, Europe's leading medical diagnostic services provider, and the existing laboratory diagnostics services provider of UEFA, the governing body of European football, has been entrusted to continue providing PCR-testing for SARS-CoV-2 at UEFA competition matches for the upcoming football season. As the 'UEFA Laboratory Diagnostics Provider 2021/2022', SYNLAB will support implementing UEFA's rigorous Return to Play Protocol, to create as the safest possible environment for teams, officials, and venue staff.

With the extension of the partnership, SYNLAB will utilize its broad European laboratory network to provide advanced diagnostics for UEFA EURO 2020, testing all 24 teams as well as officials and venue staff at the 11 dedicated match sites across Europe.

Over the course of the 2020/2021 season, SYNLAB has successfully conducted more than 160,000 PCR-tests for UEFA competition matches. SYNLAB and its partners will continue to test all players and staff for SARS-CoV-2 ahead of every match using the RT-PCR or a medically equivalent testing method. Only persons with negative results will be allowed to attend a match and have access to the stadium.

Mathieu Floreani, CEO of SYNLAB, says: "We are pleased to continue our successful and trusted partnership with UEFA. Based on SYNLAB's clear commitment to medical excellence, we will continue to make every effort to leverage our broad capabilities across Europe to ensure that testing of the players, officials, and venue staff is implemented in the best possible way. Especially in view of UEFA EURO 2020, we are proud to play our part in creating the safest possible environment for Europe's unique football event. The tournament will bring joy to millions - if not billions - of football fans in Europe and beyond in times of the COVID-19 pandemic."

Underlining UEFA's commitment to reliable testing procedures and the rigorous Return to Play protocol, Giorgio Marchetti, UEFA deputy secretary, adds: "As the fight against the COVID-19 pandemic continues, the health and well-being of players, staff, referees and everyone operating in the stadium remains to be our absolute priority. The last year has shown that partnering with an industry leader like SYNLAB allows us to ensure that all UEFA competition matches are played in an as safe as possible environment. We are looking forward to continuing this successful cooperation with SYNLAB".


For more information:

Media contact:
Florian Brueckner, FTI Consulting       

+49 (0) 160 9192 5265
Florian.Brueckner@fticonsulting.com

Investor contact:
Mark Reinhard, SYNLAB

+49 (0) 170 118 3753
Mark.Reinhard@synlab.com

 



About SYNLAB

 


10.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:

English

Company:

SYNLAB AG

Moosacher Straße 88

80809 Munich

Germany

Phone:

+49 1701183753

E-mail:

ir@synlab.com

Internet:

www.synlab.com/

ISIN:

DE000A2TSL71

WKN:

A2TSL7

Listed:

Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange

EQS News ID:

1205688


 

End of News

DGAP News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting